ArticleActa pharmaceutica Sinica. B2024

Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the

Laura García-Pupo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.